in

Gland Pharma Q3 net profit rises 7% to Rs 205 crore

Gland Pharma on Monday reported 7% year-on-year (YoY) rise in net profit to Rs 205 crores in Q3FY25.

The company reported net profit of Rs 192 crores in the same quarter of the previous year.

Revenue from operations declined 10% YoY in Q3FY25 to Rs 1384 crore.

Earnings Before Interest, Taxes,…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Time For Industry To Take Plunge Towards Making Big Investments: Finance Secretary

Alembic Pharma Q3 Results: Company posts 23% YoY decline in net profit at Rs 138 crore, revenue up 4%